Previous work nicely showed that KDM4B, being a coactivator of AR 30, drives c-Myc expression through recruitment of AR to the Myc gene enhancer in endocrine therapy resistant models of PCa 38. This evidence concerns the gene MYC and posterior cortical atrophy.